Garry Michael Kann

Garry Michael Kann

Corporate Officer/Principal at ENDONOVO THERAPEUTICS, INC.

68 year
Health Technology
Finance
Consumer Services

Profile

Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd.
He obtained an undergraduate degree from Kean University.

Garry Michael Kann active positions

CompaniesPositionStart
ENDONOVO THERAPEUTICS, INC. Corporate Officer/Principal 28/02/2022
Corporate Officer/Principal -
All active positions of Garry Michael Kann

Training of Garry Michael Kann

Kean University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Garry Michael Kann's experience

Connections

9

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ENDONOVO THERAPEUTICS, INC.

Health Technology

Private companies1

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Garry Michael Kann